Synergistic effects of C-peptide and insulin on low O2-induced ATP release from human erythrocytes

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 305, Issue 11, 2013, Pages

  Richards, Jennifer P ^a   Stephenson, Alan H ^a   Ellsworth, Mary L ^a   Sprague, Randy S ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Adenosine triphosphate; Diabetes; Microcirculation; Phosphodiesterase 3; UT 15C

Indexed keywords

ADENOSINE TRIPHOSPHATE; C PEPTIDE; HEMOGLOBIN; INSULIN; OXYGEN; PROSTACYCLIN RECEPTOR;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FILM; HEMATOCRIT; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VIVO STUDY; INHIBITION KINETICS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MUSCLE PERFUSION; OXYGEN TENSION; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SKELETAL MUSCLE; TONOMETER;

ADENOSINE TRIPHOSPHATE; DIABETES; MICROCIRCULATION; PHOSPHODIESTERASE 3; UT-15C;

ADENOSINE TRIPHOSPHATE; ADULT; AGED; C-PEPTIDE; CYCLIC AMP; DRUG SYNERGISM; ERYTHROCYTES; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OXYGEN; YOUNG ADULT;

EID: 84889595539     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00341.2013     Document Type: Article

References (46)

1. Bergfeld GR, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 26: 40-47, 1992.
2. Bo S, Gentile L, Castiglione A, Prandi V, Canil S, Ghigo E, Ciccone G. C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up. Eur J Endocrinol 167: 173-180, 2012.
3. Cebix Incorporated. A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CBX129801 (Ersatta™), Long-Acting Synthetic C-Peptide, in Type 1 Diabetes Mellitus Subjects With Mild to Moderate Diabetic Peripheral Neuropathy. Bethesda, MD: National Library of Medicine (US). 2000 (accessed July 8, 2013). Available from http://clinicaltrials.gov/show/NCT01681290NLMIdentifier:NCT01681290.
4. Dietrich HH. Red blood cell regulation of microvascular tone through adenosine triphosphate. Am J Physiol Heart Circ Physiol 278: H1294-H1298, 2000.
5. Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev 19: 608-624, 1998.
6. Ekberg K, Brismar T, Johansson BL, Lindstrom P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy. Diabetes Care 30: 71-76, 2007.
7. Ellsworth ML. The erythrocyte as a regulator of vascular tone. Am J Physiol Heart Circ Physiol 269: H2155-H2161, 1995.
8. Ellsworth ML, Ellis CG, Goldman D, Stephenson AH, Dietrich HH, Sprague RS. Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology (Bethesda) 24: 107-116, 2009.
9. Ellsworth ML, Sprague RS. Regulation of blood flow distribution in skeletal muscle: role of erythrocyte-released ATP. J Physiol 590: 4985-4991, 2012.
10. +-ATPase activity in diabetes mellitus type I. Clin Sci (Lond) 98: 283-290, 2000.
11. Forst T, Kunt T. Effects of C-peptide on microvascular blood flow and blood hemorheology. Exp Diabesity Res 5: 51-64, 2004.
12. Gambhir KK, Agarwal VR. Red blood cell insulin receptors in health and disease. Biochem Med Metab Biol 45: 133-153, 1991.
13. Gambhir KK, Archer JA, Bradley CJ. Characteristics of human erythrocyte insulin receptors. Diabetes 27: 701-708, 1978.
14. Goldman D, Fraser GM, Ellis CG, Sprague RS, Ellsworth ML, Stephenson AH. Toward a multiscale description of microvascular flow regulation: O2-dependent release of ATP from human erythrocytes and the distribution of ATP in capillary networks. Front Physiol 3: 246, 2012.
15. Hanson MS, Ellsworth ML, Achilleus D, Stephenson AH, Bowles EA, Sridharan M, Adderley S, Sprague RS. Insulin inhibits low oxygeninduced ATP release from human erythrocytes: implication for vascular control. Microcirculation 16: 424-433, 2009.
16. Hanson MS, Stephenson AH, Bowles EA, Sprague RS. Insulin inhibits human erythrocyte cAMP accumulation and ATP release: role of phosphodiesterase 3 and phosphoinositide 3-kinase. Exp Biol Med (Maywood) 235: 256-262, 2010.
17. Heding LG, Rasmussen SM. Human C-peptide in normal and diabetic subjects. Diabetologia 11: 201-206, 1975.
18. Heimann E, Jones HA, Resjo S, Manganiello VC, Stenson L, Degerman E. Expression and regulation of cyclic nucleotide phosphodiesterases in human and rat pancreatic islets. PLoS One 5: e14191, 2010.
19. Heliovaara MK, Teppo AM, Karonen SL, Tuominen JA, Ebeling P. Plasma IL-6 concentration is inversely related to insulin sensitivity, and acute-phase proteins associate with glucose and lipid metabolism in healthy subjects. Diabetes Obes Metab 7: 729-736, 2005.
20. Hills CE, Brunskill NJ. Cellular and physiological effects of C-peptide. Clin Sci (Lond) 116: 565-574, 2009.
21. Holownia P, Bishop E, Newman DJ, John WG, Price CP. Adaptation of latex-enhanced assay for percent glycohemoglobin to a Dade Dimension analyzer. Clin Chem 43: 76-84, 1997.
22. Horwitz DL, Starr JI, Mako ME, Blackard WG, Rubenstein AH. Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood. J Clin Invest 55: 1278-1283, 1975.
23. Houston DA, Burnstock G, Vanhoutte PM. Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels. J Pharmacol Exp Ther 241: 501-506, 1987.
24. Jensen ME, Messina EJ. C-peptide induces a concentration-dependent dilation of skeletal muscle arterioles only in presence of insulin. Am J Physiol Heart Circ Physiol 276: H1223-H1228, 1999.
25. Keltner Z, Meyer JA, Johnson EM, Palumbo AM, Spence DM, Reid GE. Mass spectrometric characterization and activity of zinc-activated proinsulin C-peptide and C-peptide mutants. Analyst 135: 278-288, 2010.
26. Kennedy C, Delbro D, Burnstock G. P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol 107: 161-168, 1985.
27. Lindh R, Ahmad F, Resjo S, James P, Yang JS, Fales HM, Manganiello V, Degerman E. Multisite phosphorylation of adipocyte and hepatocyte phosphodiesterase 3B. Biochim Biophys Acta 1773: 584-592, 2007.
28. Marx N, Walcher D, Raichle C, Aleksic M, Bach H, Grub M, Hombach V, Libby P, Zieske A, Homma S, Strong J. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol 24: 540-545, 2004.
29. Medawala W, McCahill P, Giebink A, Meyer J, Ku CJ, Spence DM. A molecular level understanding of zinc activation of C-peptide and its effects on cellular communication in the bloodstream. Rev Diabet Stud 6: 148-158, 2009.
30. Meyer JA, Froelich JM, Reid GE, Karunarathne WK, Spence DM. Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter. Diabetologia 51: 175-182, 2008.
31. Motte S, Pirotton S, Boeynaems JM. Heterogeneity of ATP receptors in aortic endothelial cells. Involvement of P2y and P2u receptors in inositol phosphate response. Circ Res 72: 504-510, 1993.
32. Nordquist L, Johansson M. Proinsulin C-peptide: friend or foe in the development of diabetes-associated complications? Vasc Health Risk Manag 4: 1283-1288, 2008.
33. Okada Y. Characteristics of human erythrocyte insulin binding sites. Acta Med Okayama 35: 125-135, 1981.
34. Polonsky KS, Licinio-Paixao J, Given BD, Pugh W, Rue P, Galloway J, Karrison T, Frank B. Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. J Clin Invest 77: 98-105, 1986.
35. Sprague RS, Bowles EA, Achilleus D, Ellsworth ML. Erythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle. Acta Physiol (Oxf) 202: 285-292, 2011.
36. Sprague RS, Bowles EA, Achilleus D, Stephenson AH, Ellis CG, Ellsworth ML. A selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular control. Am J Physiol Heart Circ Physiol 301: H2466-H2472, 2011.
37. Sprague RS, Bowles EA, Hanson MS, DuFaux EA, Sridharan M, Adderley S, Ellsworth ML, Stephenson AH. Prostacyclin analogs stimulate receptor-mediated cAMP synthesis and ATP release from rabbit and human erythrocytes. Microcirculation 15: 461-471, 2008.
38. Sprague RS, Hanson MS, Achilleus D, Bowles EA, Stephenson AH, Sridharan M, Adderley S, Procknow J, Ellsworth ML. Rabbit erythrocytes release ATP and dilate skeletal muscle arterioles in the presence of reduced oxygen tension. Pharmacol Rep 61: 183-190, 2009.
39. Sprague RS, Olearczyk JJ, Spence DM, Stephenson AH, Sprung RW, Lonigro AJ. Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance. Am J Physiol Heart Circ Physiol 285: H693-H700, 2003.
40. Sridharan M, Bowles EA, Richards JP, Krantic M, Davis KL, Dietrich KA, Stephenson AH, Ellsworth ML, Sprague RS. Prostacyclin receptor-mediated ATP release from erythrocytes requires the voltagedependent anion channel. Am J Physiol Heart Circ Physiol 302: H553-H559, 2012.
41. Steffes MW, Sibley S, Jackson M, Thomas W. β-cell function and the development of diabetes-related complications in the diabetes control and complications trial. Diabetes Care 26: 832-836, 2003.
42. Steiner DF. The proinsulin C-peptide-a multirole model. Exp Diabesity Res 5: 7-14, 2004.
43. Vasic D, Walcher D. C-peptide: a new mediator of atherosclerosis in diabetes. Mediators Inflamm 2012: 858692, 2012.
44. Wahren J, Ekberg K, Johansson J, Henriksson M, Pramanik A, Johansson BL, Rigler R, Jornvall H. Role of C-peptide in human physiology. Am J Physiol Endocrinol Metab 278: E759-E768, 2000.
45. Wahren J, Kallas A, Sima AA. The clinical potential of C-peptide replacement in type 1 diabetes. Diabetes 61: 761-772, 2012.
46. Wijkander J, Landstrom TR, Manganiello V, Belfrage P, Degerman E. Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogenactivated protein kinase or p70 S6 kinase. Endocrinology 139: 219-227, 1998.